Isomorphic Labs is a London-based AI-first drug discovery company spun out of Google DeepMind in 2021 and operating as an Alphabet subsidiary. Founded and led by Sir Demis Hassabis, the company applies frontier AI — including derivatives of the Nobel-winning AlphaFold system and its proprietary Unified Drug Design Engine — to accelerate the design… - View it on GitHub